1 report

The company' s key products include Neulasta (pegfilgrastim); Neupogen (filgrastim) indicated for cancer treatment; Enbrel (entanercept) for treating rheumatoid arthritis; Epogen (Erythropoietic Stimulating Agents); Aranesp (darbepoetin alfa) to treat anemia associated with chronic kidn

  • Acne Treatment
  • Autoimmune Disease
  • United States
  • Product Initiative
  • Valeant Pharmaceuticals International, Inc.